Skin Diseases, Infectious Completed Phase 3 Trials for Cefazolin (DB01327)

Also known as: Skin Disease, Infectious

IndicationStatusPhase
DBCOND0032714 (Skin Diseases, Infectious)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02276482Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)Treatment